Diagnostic Imaging Devices - Americas

  • Americas
  • The Diagnostic Imaging Devices market market in the Americas is anticipated to witness a significant growth in revenue, reaching a projected value of US$17.31bn by the year 2024.
  • This market is expected to exhibit a steady annual growth rate (CAGR 2024-2029) of 3.98%, leading to a substantial market volume of US$21.04bn by 2029.
  • When compared globally, it is noteworthy that the United States will contribute the largest share of revenue, with an estimated value of US$11,930.00m in the year 2024.
  • The demand for advanced diagnostic imaging devices in the United States is driven by the increasing prevalence of chronic diseases and the rising aging population.

Key regions: Germany, Japan, Netherlands, Spain, United States

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Diagnostic Imaging Devices market in Americas is experiencing steady growth due to increasing customer preferences for advanced medical imaging technologies, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Diagnostic Imaging Devices market in Americas are driving the demand for advanced medical imaging technologies. Customers are increasingly seeking imaging devices that offer high-quality images, faster and more accurate diagnoses, and improved patient comfort. They are also looking for devices that are portable and easy to use, allowing for more flexibility in clinical settings. Additionally, customers are demanding imaging devices that are cost-effective and provide value for money. Trends in the market are also contributing to the growth of the Diagnostic Imaging Devices market in Americas. One major trend is the increasing adoption of digital imaging technologies, such as computed tomography (CT) scanners and magnetic resonance imaging (MRI) machines. These digital imaging technologies offer higher resolution images, faster scanning times, and improved diagnostic accuracy. Another trend is the integration of artificial intelligence (AI) and machine learning algorithms into imaging devices, which can assist radiologists in analyzing and interpreting medical images more efficiently. Local special circumstances in the Americas are also influencing the development of the Diagnostic Imaging Devices market. For example, the presence of a large aging population in the region is driving the demand for imaging devices for the diagnosis and monitoring of age-related diseases, such as cardiovascular diseases and cancer. Additionally, the high prevalence of chronic diseases, such as diabetes and obesity, is increasing the need for imaging devices for early detection and treatment. Underlying macroeconomic factors are also playing a role in the growth of the Diagnostic Imaging Devices market in Americas. The increasing healthcare expenditure in the region, coupled with favorable reimbursement policies, is driving the adoption of advanced imaging technologies. Furthermore, the presence of well-established healthcare infrastructure and the availability of skilled healthcare professionals are facilitating the implementation of new imaging technologies in the region. In conclusion, the Diagnostic Imaging Devices market in Americas is experiencing steady growth due to increasing customer preferences for advanced medical imaging technologies, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. The demand for high-quality imaging devices, the adoption of digital imaging technologies, the integration of AI and machine learning, the aging population, the prevalence of chronic diseases, healthcare expenditure, reimbursement policies, healthcare infrastructure, and skilled healthcare professionals are all contributing to the development of the market.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)